“Solution”的搜索结果，显示 461-470 项，共有 9433 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   This research is being done to evaluate the safety and tolerability of the new drug, axatilimab, in combination with olaparib (a standard of care treatment) ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Jacksonville, Fla. The purpose of this study is to determine if LIF (Leukemia Inhibitory Factor) level is positively correlated with disease progression and ...

3. COVID-19 与心理健康 - 妙佑医疗国际

   因COVID-19 而担心和忧虑是常见情况。以下是如何应对和何时寻求帮助的一些建议。

4. 巨细胞病毒感染（CMV 感染） - 诊断与治疗- 妙佑医疗国际

   Kimberlin DW, et al. Cytomegalovirus infection. In: Red Book Online. 31st ed. American Academy of Pediatrics; 2018. https://redbook.solutions.aap.org ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. This is a randomized Phase 2 study of novel SEQUEnced immunotherapy (pembrolizumab) with anti-angiogenesis and chemotherapy in advanced gastric ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Jacksonville, Fla. This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Establish a prospective database of all patients with peritoneal surface malignancies seen by Dr. Travis Grotz at the Mayo Clinic, Rochester. Design and ...

8. 妙佑医疗国际的国际患者服务. 联系我们.

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate immune profile of Acute Myeloid Leukemia (AML) patients receiving Venetoclax plus Azacitidine induction chemotherapy.

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    The purpose of this study is to evaluate the safety and tolerability, identify dose-limiting toxicities (DLT) and the maximum tolerated dose (MTD and ...